AI assistant
Marksans Pharma Ltd. — Regulatory Filings 2021
Apr 6, 2021
62142_rns_2021-04-07_6b482acb-8334-4660-be8b-5953b8e17029.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [192 x 53] intentionally omitted <==
----- Start of picture text ----- ••Marksans Pharma Ltd.----- End of picture text -----
==> picture [465 x 318] intentionally omitted <==
----- Start of picture text ----- Sr. No. Particulars DetailsI Incremental borrowing done in FY (a) NilII Mandatory borrowing to be done through issuance of Not Applicabledebt securities «b) = (25% of a)III ... Actual borrowings done through debt securities in FY Nil(c)IV Shortfall in the mandatory borrowing through debt Not Applicablesecurities if any (d) = (b) - (c){If the calculated value is zero or negative, write nil}V Reasons for shortfall, if any, in mandatory borrowings Not Applicablethrough debt securitiesNote: We are not a Large Corporate as per the applicability criteria given under the SEBICircular SEBIIHOIDDHS/CIR/P/2018/144 dated November 26, 2018.;1Il ,LyV. ~Harshavardhan Panigrahi Jitendra' Sharlna .Company Secretary Chief Financial OfficerMarksans Pharma Limited Marksans Pharma LimitedE-mail: [email protected] j [email protected]Mobile: 9833982246 9820338507----- End of picture text -----
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected] www.marksanspharma.com